"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2003 | 3 | 1 | 4 |
| 2004 | 0 | 2 | 2 |
| 2005 | 5 | 4 | 9 |
| 2006 | 2 | 5 | 7 |
| 2007 | 3 | 3 | 6 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 4 | 1 | 5 |
| 2011 | 5 | 3 | 8 |
| 2012 | 3 | 2 | 5 |
| 2013 | 2 | 4 | 6 |
| 2014 | 5 | 2 | 7 |
| 2015 | 7 | 5 | 12 |
| 2016 | 4 | 3 | 7 |
| 2017 | 12 | 1 | 13 |
| 2018 | 8 | 3 | 11 |
| 2019 | 5 | 5 | 10 |
| 2020 | 7 | 4 | 11 |
| 2021 | 10 | 2 | 12 |
| 2022 | 4 | 0 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 1 | 0 | 1 |
| 2025 | 3 | 0 | 3 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention. Eur Heart J. 2026 Jun 02; 47(21):2584-2605.
-
Implementation of a cardiovascular toolkit in primary care increased women Veterans' engagement in behavior change programs: results from a non-randomized stepped wedge trial. BMC Prim Care. 2026 01 08; 27(1).
-
Cardiovascular Risk and Eye Health: A Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence. Ophthalmology. 2026 05; 133(5):645-653.
-
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial. Diabetes Care. 2025 Sep 01; 48(9):1512-1516.
-
A Review of Racial Differences and Disparities in ECG. Int J Environ Res Public Health. 2025 Feb 25; 22(3).
-
Designing an implementation science clinical trial to integrate hypertension and cardiovascular diseases care into existing HIV services package in Botswana (InterCARE). Trials. 2024 Jul 29; 25(1):510.
-
Functional Hypothalamic Amenorrhea and Preclinical Cardiovascular Disease. J Clin Endocrinol Metab. 2023 12 21; 109(1):e51-e57.
-
Cardio-renal-metabolic disease in primary care setting. Diabetes Metab Res Rev. 2024 Mar; 40(3):e3755.
-
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 11; 82(2):161-170.
-
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2023 02; 37(2):108389.